Your browser doesn't support javascript.
loading
Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in osteosarcoma cells.
Feng, Tao; Qiao, Guanglei; Feng, Li; Qi, Weixiang; Huang, Yujing; Yao, Yang; Shen, Zan.
Afiliação
  • Feng T; Department of Oncology, Affiliated People's 6th Hospital, Shanghai Jiaotong University, Shanghai 200233, P.R. China.
  • Qiao G; Department of Oncology, Affiliated People's 6th Hospital, Shanghai Jiaotong University, Shanghai 200233, P.R. China.
  • Feng L; Department of Pharmacy, The Donggang People's Hospital, Rizhao, Shandong 276800, P.R. China.
  • Qi W; Department of Oncology, Affiliated People's 6th Hospital, Shanghai Jiaotong University, Shanghai 200233, P.R. China.
  • Huang Y; Department of Oncology, Affiliated People's 6th Hospital, Shanghai Jiaotong University, Shanghai 200233, P.R. China.
  • Yao Y; Department of Oncology, Affiliated People's 6th Hospital, Shanghai Jiaotong University, Shanghai 200233, P.R. China.
  • Shen Z; Department of Oncology, Affiliated People's 6th Hospital, Shanghai Jiaotong University, Shanghai 200233, P.R. China.
Mol Med Rep ; 10(6): 2985-92, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25310700
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Óxidos / Arsenicais / Neoplasias Ósseas / Doxorrubicina / Osteossarcoma / Resistencia a Medicamentos Antineoplásicos / Estatmina / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Óxidos / Arsenicais / Neoplasias Ósseas / Doxorrubicina / Osteossarcoma / Resistencia a Medicamentos Antineoplásicos / Estatmina / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article